article thumbnail

The next innovation revolution—powered by AI

McKinsey Sustainabilty

He and his research collaborators found that the number of new drugs approved per billion US dollars spent on R&D halved roughly every nine years between 1950 and 2011, falling around 80-fold in inflation-adjusted terms (although the decline appears to have stabilized somewhat in the past decade) (Exhibit 3). Scannell et al.,